{
    "title": "113_hr1024",
    "content": "SECTION 1. SHORT TITLE.\n\n    This Act may be cited as the ``Medication Therapy Management \nEmpowerment Act of 2013''.\n\nSEC. 2. ACCESS TO SERVICES UNDER MEDICATION THERAPY MANAGEMENT PROGRAMS \n              FOR MEDICARE PART D ELIGIBLE INDIVIDUALS WITH SINGLE \n              CHRONIC DISEASES.\n\n    Section 1860D-4(c)(2)(A) of the Social Security Act (42 U.S.C. \n1395w-104(c)(2)(A)) is amended--\n            (1) in clause (ii), by striking subclause (I) and inserting \n        the following:\n                                    ``(I) have--\n                                            ``(aa) multiple chronic \n                                        diseases (such as diabetes, \n                                        asthma, hypertension, \n                                        hyperlipidemia, and congestive \n                                        heart failure); or\n                                            ``(bb) subject to clause \n                                        (iii), any single chronic \n                                        disease, including diabetes, \n                                        hypertension, heart failure, \n                                        dyslipidemia, respiratory \n                                        disease (such as asthma, \n                                        chronic obstructive pulmonary \n                                        disease or chronic lung \n                                        disorder), bone disease-\n                                        arthritis (such as osteoporosis \n                                        or osteoarthritis), rheumatoid \n                                        arthritis, or mental health \n                                        disorder (such as depression, \n                                        schizophrenia, or bipolar \n                                        disorder).''; and\n            (2) by adding at the end the following:\n                            ``(iii) Determinations relating to program \n                        costs for including individuals with single \n                        chronic diseases.--\n                                    ``(I) Initial determinations.--With \n                                regard to any single chronic disease, \n                                clause (ii)(I)(bb) shall only be \n                                applied if the Chief Actuary for the \n                                Centers for Medicare & Medicaid \n                                Services determines that the \n                                application of such clause with regard \n                                to such disease is not projected to \n                                increase overall costs to the Medicare \n                                program under this title over the five \n                                year period beginning on the date of \n                                determination.\n                                    ``(II) Review of determinations.--\n                                In the case that clause (ii)(I)(bb) is \n                                applied with respect to a single \n                                chronic disease pursuant to a \n                                determination under subclause (I), not \n                                later than five years after such date \n                                of determination, the Chief Actuary for \n                                the Centers for Medicare & Medicaid \n                                Services shall review the effect of the \n                                application of such clause with respect \n                                to such disease on the actual cost of \n                                the Medicare program under this title \n                                during such five years. Based on such \n                                review, if the Chief Actuary is unable \n                                to determine that, with regard to such \n                                single chronic disease, the application \n                                of such clause did not increase costs \n                                to the Federal government under the \n                                Medicare program under this title over \n                                such period, then the Secretary shall \n                                review the findings of the Chief \n                                Actuary and determine whether such \n                                clause shall continue to be applied \n                                with regard to such single chronic \n                                disease. In conducting such review and \n                                making such determination, the \n                                Secretary shall consider the extent to \n                                which the application of such clause \n                                with regard to such single chronic \n                                disease effects the health outcomes of \n                                part D eligible individuals and any \n                                savings and costs to the Federal \n                                government under the Medicare program \n                                under this title.''."
}